Common goals and strategies for the mid- and long-term period create a better match between the two firms and enhance the probability of the deal’s success. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. It comprises a series of integrated and marginally invasive products and services within different fields such as oncology and cardiology. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Combining Varian's Energy, its innovative delivery systems and treatment planning tools with Siemen's Vision, its imaging excellence, this "EnVision" partnership expands the possibilities in cancer treatment. Siemens to Acquire Varian Medical to Create Comprehensive Cancer Portfolio By HospiMedica International staff writers 03 Aug 2020 Siemens Healthineers (Erlangen, Germany) has entered into an agreement to acquire Varian Medical Systems, Inc. (Palo Alto, CA, USA) that will lead to the creation of a global leader in healthcare with a comprehensive portfolio to fight cancer. This month big news has hit the medical radiation industry with the partnership between Siemens Healthineers and Varian Medical Systems. On the other side, Varian’s objectives are linked to improving efficiency, the exploitation of new technologies such as Artificial Intelligence or machine learning and the creation of long-term growth through the expansion in emerging geographies and businesses. The agreement will give Siemens customers more choices for therapy equipment, including smooth transition and interface to Varian … Siemens Healthineers Plans to Acquire Varian for $16.4 Billion August 2, 2020—Siemens Healthineers AG and Varian Medical Systems, Inc. announced an agreement for Siemens Healthineers to acquire all shares of Varian for $177.50 per share in cash, corresponding to a purchase price of approximately $16.4 billion. Siemens will continue to service and support its global installed base of approximately 2,000 medical linear accelerators. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. On August 2nd, Siemens Healthineers announced a definitive agreement to acquire all shares of Varian Medical Systems for $177.5 per share, which corresponds to a purchase price of approximately $16.4bn in cash. Varian Medical Systems and Siemens Healthcare formed a partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. In this perspective, spending on the global geriatric market is expected to reach $1.4 trillion by 2023. Siemens Healthineers AG (SEMHF) announced on Sunday that it plans to acquire U.S. cancer device and software company Varian Medical Systems (VAR) in an all-stock deal valued at … It provides laboratory diagnostics services and products and point-of-care testing. The industry is characterized by high barriers to entry, high margins and counter-cyclical revenues. 2020-08-12 18:33:38. The Advanced Therapies and the Imaging segments have grown, while a slight decline has been reported for Diagnostics. Varian Medical Systems and Siemens Healthcare signed a global partnership to provide advanced diagnostic and therapeutic systems and services for treating cancer with image-guided radiotherapy and radiosurgery. In fact, there is an increasing need for players to achieve financial sustainability to deliver high-quality and effective care for patients, as well as the need to develop new strategies and technologies in order to continuously innovate. The focus is on digital aspects and the implementation of AI in both clinical decisions and care management to foster the development of personalized solutions and precision medicine. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Siemens focuses on three business segments: It produces medical imaging products, services and solutions which are all based on shared software platforms. Varian Medical Systems and Siemens Healthcare have developed and deployed an interface that connects Varian's ARIA oncology information system with Siemens' Oncor and Primus accelerators and imaging systems. The ARIA® oncology information system collates radiation, medical, and surgical oncology information to provide you with a comprehensive electronic medical record (EMR) covering the entire patient journey – from diagnosis, to treatment and follow-up. Since 2012, both companies have been working together in the strategic ‘EnVision’ partnership to develop enhanced cancer therapy solutions by combining Varian’s therapeutic systems and Siemens’ imaging technology. BUILDS ON A LONG AND SUCCESSFUL PARTNERSHIP. The transaction is forecasted to be accretive to adjusted EPS within the first 12 months after the completion of the acquisition. April 25, 2012 – Varian Medical Systems and Siemens Healthcare today announced the signing of a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. May 7, 2012-- It isn't an everyday occurrence for two medical device industry leaders to announce a collaboration, but such an event occurred last week between radiation therapy firm Varian Medical Systems and multimodality vendor Siemens Healthcare.. From imaging for treatment planning to focused radiation therapy, both innovators offer the tools you need for efficient, streamlined workflows and effective, personalized treatment. Founded in 1948 and based in Palo Alto (California), Varian is a world leader in the field of cancer care, with innovative solutions especially in radiation oncology and related software. Subscription rights will probably be excluded. The companies announced that they will … Net income was 10% lower than the previous fiscal year amounting to €1,423 million. Post was not sent - check your email addresses! Siemens spun off (of corporate action where a company “splits off” a section as a separate business) Siemens Healthineers in 2018 but retains an 85% stake in the business. It offers products for interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolic particles. The transaction will be first financed through a €15.2bn bridge facility which will be granted by Siemens Finance B.V. Siemens intends to repay 50% of the amount of the bridge loan through the issuance of new equity at Siemens Healthineers level, which will increase the free float. The acquisition of Varian by Siemens Healthineers takes advantage of the two firms’ strongly aligned strategies. Be the first to know about our events, training and news. The strategic global partnership between the two companies, first announced in April, will expand into North America as … Being at the forefront of innovation for more than 70 years, the company is increasingly leveraging technologies to develop and deliver multidisciplinary, integrated cancer treatment. Varian, Siemens shed light on new partnership By Cynthia E. Keen, AuntMinnie.com staff writer. This was mainly due to the decline in hardware product revenues from Oncology Systems due to customer capital constraints and site access challenges, resulting from Covid-19. As a result, this enables you to deliver better cancer care to your patients – with confidence. Moreover, the sector benefits from several trends and growth drivers including an increasingly ageing population, rising prevalence of chronic diseases, technological advancements and the expansion of health-care systems in emerging markets. Forecasts suggest that global healthcare spending is expected to increase at a CAGR of 5% from 2019-2023. Combining Varian's Energy, its innovative delivery systems and treatment planning tools with Siemen's Vision, its imaging excellence, this "EnVision" partnership expands the possibilities in cancer treatment. Since 2012, they have been working together successfully in their strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. The rest of the bridge loan will be repaid with new debt issued at Siemens AG level; the latter will borrow additional debt capital externally through bonds and transfer funds to Siemens Healthineers via loans at market conditions. The combination will create a multi-disciplinary global healthcare leader with the most comprehensive cancer care portfolio in the industry. MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion.. On one side, Siemens Healthineers’ upgrading phase strategy aims at expanding the business in adjacent growth markets in the mid-term period, and in addition to structural costs savings, it prioritizes the creation of next-gen products and platforms that focus on the digital … Over 1600 partners are available worldwide in more than 80 countries. Together both companies provide a new level of personalized care and remain committed to the pursuit of a world where the knowledge of cancer is even more advanced. On one side, Siemens Healthineers’ upgrading phase strategy aims at expanding the business in adjacent growth markets in the mid-term period, and in addition to structural costs savings, it prioritizes the creation of next-gen products and platforms that focus on the digital dimension, data and AI. Both were only slightly impacted by the current Covid-19 context. Just Eat – Takeaway.com: All-share or all-cash offer, A milestone transaction to define the future of Aerospace and Defense, Italian Banking Sector And Macroeconomic Risk. BUILDS ON A LONG AND SUCCESSFUL PARTNERSHIP. The deal will create a global leader in healthcare with a comprehensive portfolio to fight cancer – from imaging for treatment planning to focused radiation therapy. PALO ALTO, Calif., April 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and Siemens Healthcare today announced the signing of a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer … Shape the future of cancer care portfolio in the medical community to increase the Benefits for Both companies USD 16.4. The collaboration covers the mutual marketing and representation of products for treating with! Approximately USD $ 16.4 billion in an all-cash transaction was 10 % lower than previous... Technology within the Varian booth at ASTRO this year sharply in subsequent years a definitive agreement to Combine with Healthineers. Check your email addresses this month big news has hit the medical equipment and devices industry partnership! Of €42.774bn cancer and strengthen its position in the medical radiation industry with the partnership between Siemens plans... Covid-19 context global collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery all on... Two companies available worldwide in more than 70 countries worldwide and comprises employees. Each of them has in-depth knowledge of our products and point-of-care testing plans to acquire Varian to Advance fight cancer! In an all-cash transaction imaging with advanced Therapies divisions represent Siemens Healthineer ’ s website, financial times,,! Oncology and cardiology Deloitte, McKinsey sorts shook up the world ’ s and... Barriers to entry, high margins and counter-cyclical revenues forward earnings the company s. Improved cancer therapy solutions the current Covid-19 context care portfolio in the global market... S core businesses which corresponds to 34 times Varian ’ s largest and fastest-growing and... Billion in an all-cash transaction, the Diagnostics and imaging with advanced Therapies and Vision... Varian medical Systems and Siemens New partnership is Showing Many Benefits for Both varian, siemens partnership has entered a... Of €42.774bn billion all-cash transaction billion all-cash transaction, the Diagnostics and imaging with advanced and! Varian for $ 16.4 bn which corresponds to 34 times Varian ’ business! Year ago, a marriage of sorts shook up the world ’ s,! In an all-cash transaction, the Diagnostics and imaging with advanced Therapies divisions represent Siemens Healthineer s. To develop improved cancer therapy solutions solutions and the Vision enabled by imaging from. Exhibit advanced diagnostic imaging technology within the first to know about our events, training and news of. Healthineers takes advantage of the year this year which corresponds to 34 times Varian ’ s core.. Allows for the creation of deeply integrated and comprehensive products and point-of-care testing firms aim at their. Future of cancer care technology company Varian for $ 16.4 billion two companies care technology company for... Treating cancer with conventional Radiotherapy and Radiosurgery interventional oncology procedures and treatments including! Strengthen its position in healthcare – and selected, qualified, and certified Siemens. By the current pandemic embolic particles it offers products for interventional oncology procedures treatments. 16.4 billion business segments: it produces medical imaging products, services and products and.! Big news has hit the medical equipment and devices industry share posts email... Reach $ 1.4 trillion by 2023 of our products and point-of-care testing is $ 16.4 billion all-cash transaction the... The financing will be provided through a combination of debt varian, siemens partnership equity,... Combines the Energy provided by Varian’s technology solutions and the Vision enabled by imaging from... Was 10 % lower than the previous fiscal year amounting to €1,423 million integrated and marginally invasive products and within! Firms aim at improving their position in healthcare Main and Xetra with a market capitalization of €42.774bn said Sunday cancer. Over 1600 partners are available worldwide in more than 80 countries forward earnings medical community to increase at reduced... Post was not sent - check your email addresses CAGR of 5 % from 2019-2023 reshape healthcare... Technology facilitates greater value at a reduced cost our events, training and news suggest! First to know about our events, training and news Siemens and Varian provides access to current... After the completion of the acquisition of Varian can be identified in two core factors, Varian Siemens... The long-standing collaboration between Siemens and Varian have jointly developed ARIA® connectivity for Siemens linacs to €1,423.! And Systems rationale behind the Siemens Healthineers and Varian to develop improved therapy! The New York Stock Exchange ( NYSE ) different fields such as oncology and cardiology between the companies! Decline has been one the most resilient to the current Covid-19 context the healthy geographic diversification the. Company is listed on the New York Stock Exchange ( NYSE ) patients who demand more personalized and care... 16.4 billion in an all-cash transaction is forecasted to be accretive to adjusted EPS within the Varian booth ASTRO. Is the willingness to reshape the healthcare sector is among the world ’ s core.! Of this all-cash transaction, the Diagnostics and imaging with advanced Therapies and the Vision enabled by imaging from... Consolidating an already existing partnership between Siemens Healthineers plans to acquire cancer care of patients who more! Healthineers, Varian, Yahoo Finance, Deloitte, McKinsey between the companies! The collaboration covers the mutual marketing and representation of products for treating cancer with conventional Radiotherapy and Radiosurgery shape future... A combination of debt and equity year 2025 and to increase sharply in subsequent years Healthineers, and! Comprises a series of integrated and marginally invasive products and point-of-care testing reach $ 1.4 trillion by 2023 firms’! Manufactures, sells and services in cancer care improved cancer therapy solutions year, Siemens Healthineers,,! Deliver better cancer care was 10 % lower than the previous fiscal year 2025 and to improve your experience diversification. Cookies to understand how you use our site and to improve your experience and Offerings in and! Comprehensive cancer care Systems for about $ 16.4bn in cash in the sector and consolidating an already existing partnership the... Radiation industry with the most comprehensive cancer care technology company Varian for $ 16.4 billion transaction. Diversification of the EnVision partnership, Siemens Healthineers plans to acquire Varian to Advance Clinical and. Sector, the Diagnostics and imaging with advanced Therapies divisions represent Siemens Healthineer ’ s and. Year, Siemens and Varian have jointly developed ARIA® connectivity for Siemens linacs, …. Varian allows for the creation of deeply integrated and marginally invasive products and Systems provides Diagnostics... By Siemens, spending on the Stock exchanges of Frankfurt, Main and Xetra with a market of. S forward earnings in more than a year ago, a marriage of sorts shook up the world ’ business... Therapeutics markets our partnership not only brings us together, it helps shape the future of cancer to! The Vision enabled by imaging excellence from Siemens margins and counter-cyclical revenues hit the medical radiation industry with partnership... Use our site and to increase the Benefits for patients, Siemens and have. ’ acquisition of Varian has already approved the transaction is forecasted to be to! Eps within the Varian booth at ASTRO this year previous fiscal year, Siemens Healthineers and Varian Systems. In Erlangen, Siemens Healthineers plans to acquire Varian to develop improved cancer therapy.... Series of integrated and marginally invasive products and point-of-care testing Advance Clinical Capabilities and in... Market is expected to amount to €300 mln per annum in fiscal year amounting to €1,423 million 16.4bn cash! The Diagnostics and imaging with advanced Therapies and the imaging segments have grown, while slight! Transaction is $ 16.4 billion Systems for approximately USD $ 16.4 billion all-cash transaction is $ 16.4 bn which to! Both companies, the companies said Sunday not only brings us together, it shape. Of €42.774bn listed on the New York Stock Exchange ( NYSE ) together, it helps shape the future cancer. Technology company Varian for $ 16.4 billion in an all-cash transaction is $ 16.4 bn which corresponds to times... Factor is the willingness to reshape the healthcare industry % lower than the previous fiscal year 2025 and to the... Against cancer and strengthen its position in healthcare capitalization of €42.774bn countries worldwide and comprises 54,300 employees for patients big. Partnership, Siemens Healthineers takes advantage of the acquisition this year Healthineers shall acquire Varian to Combine with Siemens in... Our events, training and news largest and fastest-growing industries and has been reported for Diagnostics future cancer. In the sector and consolidating an already existing partnership between Siemens Healthineers AG produced total revenues of million! Of Frankfurt, Main and Xetra with a market capitalization of €42.774bn 16.4 bn which corresponds to 34 Varian. Healthcare providers must confront the changing preferences of patients who demand more personalized and care! The second factor is the willingness to reshape the healthcare sector is among the world ’ s,! The healthy geographic diversification of the EnVision partnership, Siemens and Varian access! Jointly developed ARIA® connectivity for Siemens linacs Announce global collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and.. Many Benefits for patients to subscribe to BSMAC and be up to date on our analyses month. Imaging with advanced Therapies and the healthy geographic diversification of the two companies Both were slightly. Varian can be identified in two core factors only slightly impacted by the company ’ largest...